Bellevue Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bellevue Group’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-21,500	Closed	-$2.21M	–	205
2021 Q4	$2.21M	Sell	21,500 -35,500	-62%	-$3.41M	0.02%	143
2021 Q3	$4.99M	Sell	57,000 -13,500	-19%	-$1.22M	0.05%	129
2021 Q2	$6.31M	Buy	70,500 +51,500	+271%	+$4.35M	0.06%	129
2021 Q1	$1.44M	Buy	+19,000	New	+$1.43M	0.02%	151
2020 Q2	–	Sell	-61,900	Closed	-$2.44M	–	228
2020 Q1	$2.44M	Buy	61,900 +16,300	+36%	+$953K	0.05%	127
2019 Q4	$2.71M	Sell	45,600 -16,400	-26%	-$882K	0.04%	122
2019 Q3	$3.3M	Hold	62,000	–	–	0.06%	119
2019 Q2	$3.17M	Buy	62,000 +14,800	+31%	+$689K	0.05%	119
2019 Q1	$2.44M	Buy	+47,200	New	+$2.29M	0.13%	101
2018 Q4	–	Sell	-26,156	Closed	-$1.35M	–	144
2018 Q3	$1.35M	Sell	26,156 -500	-2%	-$24.5K	0.09%	117
2018 Q2	$1.25M	Buy	+26,656	New	+$1.1M	0.11%	112

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bellevue Group's SYNH Position: Q1 2022 in Review

Bellevue Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 21,500 shares — an estimated $2.21M sold.

Bellevue Group first reported a position in SYNH in Q2 2018 and held it in 11 quarters. The position peaked at $6.31M in Q2 2021. 366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

Bellevue Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
Bellevue Group sold 21,500 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $2.21M.
Bellevue Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2018 and held it in 11 quarters.
Bellevue Group's Syneos Health, Inc. Class A Common Stock position peaked at $6.31M in Q2 2021.
366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on Bellevue Group's 13F filing for Q1 2022, filed 13 May 2022.